Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Chr Hansen
Chr Hansen
Activities:
Ingredients
Research & Development
Active Nutrition
Food
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Sustainability
Novozymes and Chr. Hansen join forces to create Novonesis
The two legacy companies collaborate to offer biosolutions to over 30 different industries
Chr Hansen and Lonza appoint new CEO for BacThera
Chr Hansen and Lonza joint venture company focuses on live-biotherapeutics has appointed Lukas Schüpbach as CEO
Ingredients
Chr. Hansen and Lonza joint venture: Ready for contract manufacturing
Companies have received the relevant approvals from anti-trust regulators for the 50/50 live biotherapeutic joint venture, BacThera
Manufacturing
Lonza and Chr. Hansen joint venture taps into microbiome boom
Companies engage in a three-year plan to provide a full supply chain offering for production of bacteria strains for therapeutic use
Design & Build
AF wins €5.5 million contract to modernise Chr Hansen plant
Will install a complete fermentation line for the production of probiotics at plant in Denmark
Subscribe now